SlideShare a Scribd company logo
1 of 7
‫ومكافحت‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬‫ه‬
‫ال‬ ‫التهاب‬ ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬‫كبد‬
‫البند‬7‫من‬‫األعمال‬ ‫جدول‬
‫المتوسط‬ ‫لشـرق‬ ‫اإلقليمية‬ ‫للجنة‬ ‫والستون‬ ‫الثانية‬ ‫الدورة‬
5-8‫األول‬ ‫تشرين‬/‫أكتوبر‬2015‫الكويت‬ ،
1
ً‫ا‬‫صامت‬ ً‫ء‬‫وبا‬ ‫طويلة‬ ‫لفترات‬ ‫الكبد‬ ‫التهاب‬ ‫ظل‬:
‫األرواح‬ ‫في‬ ‫كبيرة‬ ‫خسائر‬-‫التوعية‬ ‫قصور‬
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
Malaria HIV TB Hepatitis
‫مليون‬
‫العالمية‬ ‫الوفيات‬
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
Malaria HIV TB Hepatitis
‫المتوسط‬ ‫شرق‬ ‫إقليم‬ ‫في‬ ‫الوفيات‬
Hepatitis C
Hepatitis B
Hepatitis
A&E
 2000  2013
‫البيانات‬ ‫مصدر‬:،‫المرض‬ ‫عبء‬ ‫حول‬ ‫العالمية‬ ‫الدراسة‬2013 (GBD 2013)
‫الصحة‬ ‫مجال‬ ‫في‬ ‫والتقييم‬ ‫القياسات‬ ‫معهد‬ ‫المتحدة‬ ‫الواليات‬ ،‫سياتل‬(IHME)،2014.‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬
‫الكبد‬ ‫التهاب‬2
‫العالمي‬ ‫الصعيد‬ ‫على‬ ‫الجديدة‬ ‫التطورات‬
•‫تحم‬ ‫ويمكن‬ ‫ال‬ّ‫ع‬‫وف‬ ‫جديد‬ ‫أفضل‬ ‫عالج‬‫له‬
•‫بالعمل‬ ‫وااللتزام‬ ‫العالمي‬ ‫الوعي‬ ‫زيادة‬:
–‫الخطط‬‫الوطنية‬ ‫والموارد‬
–‫المدني‬ ‫المجتمع‬ ‫مشاركة‬
–‫العالميون‬ ‫الشركاء‬
–‫العالمية‬ ‫الصحة‬ ‫جمعية‬2014‫؛‬‫دعوة‬
‫الكبد‬ ‫التهاب‬ ‫على‬ ‫للقضاء‬ ‫مستجدة‬‫؛‬
–‫المستدامة‬ ‫التنمية‬ ‫أهداف‬
‫ا‬ ‫اللتهاب‬ ‫العالمي‬ ‫التحالف‬ ،‫بيك‬ ‫راقيل‬‫لكبد‬:
"‫العالج‬ ‫أسعار‬ ‫ض‬ِّ‫نخف‬ ‫أن‬ ‫علينا‬."
‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬
‫الكبد‬ ‫التهاب‬3
‫الكبد‬ ‫اللتهاب‬ ‫العالمية‬ ‫االستراتيجية‬:
‫لنا‬ ‫معروفة‬ ‫الة‬‫الفع‬ ‫التدخالت‬ ‫أهم‬
•‫الكبد‬ ‫التهاب‬ ‫ضد‬ ‫التطعيم‬B(‫الوالدة‬ ‫عند‬ ‫اللقاح‬ ‫جرعة‬ ‫ذلك‬ ‫في‬ ‫بما‬)
•‫المأمون‬ ‫والدم‬ ‫اآلمن‬ ‫الحقن‬ ‫ممارسات‬
•‫الضرر‬ ‫من‬ ‫الحد‬‫لمتعاطي‬‫ي‬‫المخدرات‬
•‫المأمون‬ ‫الجنسي‬ ‫السلوك‬ ‫تشجيع‬
•‫الكبد‬ ‫التهاب‬ ‫عالج‬B
•‫الكبد‬ ‫التهاب‬ ‫عالج‬C
‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬
‫الكبد‬ ‫التهاب‬4
‫الكبد‬ ‫اللتهاب‬ ‫العالمية‬ ‫االستراتيجية‬:‫ال‬‫غايات‬
•‫باألثر‬ ‫الخاصة‬ ‫الغايات‬ ‫مقترح‬(‫بحلول‬2030)
•‫التدخالت‬ ‫بأهم‬ ‫التغطية‬ ‫غايات‬ ‫تدعمها‬
‫التهاب‬ ‫من‬ ‫الجديدة‬ ‫الحاالت‬ ‫خفض‬
‫الكبد‬B‫و‬C‫بنسبة‬90%
‫التهاب‬ ‫عن‬ ‫الناجمة‬ ‫الوفيات‬ ‫خفض‬
‫الكبد‬B‫و‬C‫بنسبة‬65%
‫التدخل‬،‫األساسية‬ ‫النسبة‬
2015
20202030
‫الكبد‬ ‫التهاب‬ ‫ضد‬ ‫التطعيم‬B
‫الكبد‬ ‫التهاب‬ ‫ضد‬ ‫التطعيم‬B‫عند‬
‫الوالدة‬
81%
38%
90%
50%
90%
90%
‫اآلمن‬ ‫الحقن‬5%‫بنسبة‬ ‫تغطية‬50%90%
‫الكبد‬ ‫التهاب‬ ‫عالج‬B‫من‬ ‫أقل‬1%‫عالج‬8‫شخص‬ ‫ماليين‬
(5‫الكبد‬ ‫التهاب‬ ‫من‬ ‫ماليين‬B،
‫و‬3‫الكبد‬ ‫التهاب‬ ‫من‬ ‫ماليين‬C)
80%
‫الكبد‬ ‫التهاب‬ ‫عالج‬C‫من‬ ‫أقل‬1%80%
‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬
‫الكبد‬ ‫التهاب‬5
‫اإلقل‬ ‫في‬ ‫المقترحة‬ ‫المستقبلية‬ ‫الخطوات‬‫يم‬
•‫والبلدا‬ ‫للمنظمة‬ ‫اإلقليمية‬ ‫العمل‬ ‫خطة‬‫ن‬
•‫إجراءات‬‫للظروف‬ ‫مالئمة‬‫البلدان‬ ‫في‬
(‫الوطنية‬ ‫بالخطط‬ ‫تسترشد‬،‫وتست‬‫إلى‬ ‫ند‬
‫المرض‬ ‫عبء‬ ‫تحليل‬،‫على‬ ‫وتركز‬
‫فاعلية‬ ‫األكثر‬ ‫االستثمارات‬)
‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬
‫الكبد‬ ‫التهاب‬6
ً‫ا‬‫وشكر‬ً‫ال‬‫جزي‬
http://www.emro.who.int/health-topics/hepatitis/index.html
‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬
‫الكبد‬ ‫التهاب‬7

More Related Content

Viewers also liked

علاج جديد للملاريا
علاج جديد للملاريا علاج جديد للملاريا
علاج جديد للملاريا Mohamed Alashram
 
سكاكين لقطع الجينات
سكاكين لقطع الجيناتسكاكين لقطع الجينات
سكاكين لقطع الجيناتMohamed Alashram
 
Applied Bioinformatics & Chemoinformatics: Techniques, Tools, and Opportunities
Applied Bioinformatics & Chemoinformatics: Techniques, Tools, and OpportunitiesApplied Bioinformatics & Chemoinformatics: Techniques, Tools, and Opportunities
Applied Bioinformatics & Chemoinformatics: Techniques, Tools, and OpportunitiesHezekiah Fatoki
 
FORENSIC DNA PROFILING: Strengths and Limitations
FORENSIC DNA PROFILING: Strengths and LimitationsFORENSIC DNA PROFILING: Strengths and Limitations
FORENSIC DNA PROFILING: Strengths and LimitationsHezekiah Fatoki
 
قسم مكافحة العدوى Department of infection control
قسم مكافحة العدوى Department of infection controlقسم مكافحة العدوى Department of infection control
قسم مكافحة العدوى Department of infection controlHayat abdulhamid
 
(2016 11-17)razonamiento clinico leishmaniasis(ppt)
(2016 11-17)razonamiento clinico leishmaniasis(ppt)(2016 11-17)razonamiento clinico leishmaniasis(ppt)
(2016 11-17)razonamiento clinico leishmaniasis(ppt)UDMAFyC SECTOR ZARAGOZA II
 
DNA Analysis
DNA Analysis DNA Analysis
DNA Analysis Yosok Pun
 
Standard precaution
Standard precautionStandard precaution
Standard precautionsarahammam
 
Infection Control
Infection ControlInfection Control
Infection Controljjmidwife1
 

Viewers also liked (20)

علاج جديد للملاريا
علاج جديد للملاريا علاج جديد للملاريا
علاج جديد للملاريا
 
سكاكين لقطع الجينات
سكاكين لقطع الجيناتسكاكين لقطع الجينات
سكاكين لقطع الجينات
 
التيلومير
التيلوميرالتيلومير
التيلومير
 
Dna in forensics
Dna in forensicsDna in forensics
Dna in forensics
 
Applied Bioinformatics & Chemoinformatics: Techniques, Tools, and Opportunities
Applied Bioinformatics & Chemoinformatics: Techniques, Tools, and OpportunitiesApplied Bioinformatics & Chemoinformatics: Techniques, Tools, and Opportunities
Applied Bioinformatics & Chemoinformatics: Techniques, Tools, and Opportunities
 
الكبد
الكبدالكبد
الكبد
 
تضاعف الحامض النووي Dna
تضاعف الحامض النووي Dnaتضاعف الحامض النووي Dna
تضاعف الحامض النووي Dna
 
Paper from mokhtar thesis
Paper from mokhtar thesisPaper from mokhtar thesis
Paper from mokhtar thesis
 
FORENSIC DNA PROFILING: Strengths and Limitations
FORENSIC DNA PROFILING: Strengths and LimitationsFORENSIC DNA PROFILING: Strengths and Limitations
FORENSIC DNA PROFILING: Strengths and Limitations
 
Viruses
VirusesViruses
Viruses
 
قسم مكافحة العدوى Department of infection control
قسم مكافحة العدوى Department of infection controlقسم مكافحة العدوى Department of infection control
قسم مكافحة العدوى Department of infection control
 
DNA FORENSIC ANALYSIS
DNA FORENSIC ANALYSISDNA FORENSIC ANALYSIS
DNA FORENSIC ANALYSIS
 
2017-01-10.Diarrea (DOC)
2017-01-10.Diarrea (DOC)2017-01-10.Diarrea (DOC)
2017-01-10.Diarrea (DOC)
 
(2016 11-17)razonamiento clinico leishmaniasis(ppt)
(2016 11-17)razonamiento clinico leishmaniasis(ppt)(2016 11-17)razonamiento clinico leishmaniasis(ppt)
(2016 11-17)razonamiento clinico leishmaniasis(ppt)
 
DNA Analysis
DNA Analysis DNA Analysis
DNA Analysis
 
Dna forensic
Dna forensicDna forensic
Dna forensic
 
الوقاية من تسوس الأسنان وإلتهاب اللثة
الوقاية من تسوس الأسنان وإلتهاب اللثةالوقاية من تسوس الأسنان وإلتهاب اللثة
الوقاية من تسوس الأسنان وإلتهاب اللثة
 
Dna fingerprinting
Dna fingerprintingDna fingerprinting
Dna fingerprinting
 
Standard precaution
Standard precautionStandard precaution
Standard precaution
 
Infection Control
Infection ControlInfection Control
Infection Control
 

More from WHO Regional Office for the Eastern Mediterranean

More from WHO Regional Office for the Eastern Mediterranean (20)

Introduction to the report on implementing Vision 2023.pptx
Introduction to the report on implementing Vision 2023.pptxIntroduction to the report on implementing Vision 2023.pptx
Introduction to the report on implementing Vision 2023.pptx
 
The 14th WHO General Programme of Work.pptx
The 14th WHO General Programme of Work.pptxThe 14th WHO General Programme of Work.pptx
The 14th WHO General Programme of Work.pptx
 
Transformation update.pptx
Transformation update.pptxTransformation update.pptx
Transformation update.pptx
 
Review of the draft provisional agenda of the 154th Session of the WHO Execut...
Review of the draft provisional agenda of the 154th Session of the WHO Execut...Review of the draft provisional agenda of the 154th Session of the WHO Execut...
Review of the draft provisional agenda of the 154th Session of the WHO Execut...
 
Resolutions and decisions of regional interest adopted by the Seventy-sixth W...
Resolutions and decisions of regional interest adopted by the Seventy-sixth W...Resolutions and decisions of regional interest adopted by the Seventy-sixth W...
Resolutions and decisions of regional interest adopted by the Seventy-sixth W...
 
World Health Assembly and Executive Board.pptx
World Health Assembly and Executive Board.pptxWorld Health Assembly and Executive Board.pptx
World Health Assembly and Executive Board.pptx
 
A sustainable, integrated approach to the prevention, control and elimination...
A sustainable, integrated approach to the prevention, control and elimination...A sustainable, integrated approach to the prevention, control and elimination...
A sustainable, integrated approach to the prevention, control and elimination...
 
World Health Assembly and Executive Board – Programme and budget matters
World Health Assembly and Executive Board – Programme and budget mattersWorld Health Assembly and Executive Board – Programme and budget matters
World Health Assembly and Executive Board – Programme and budget matters
 
Climate change, health and environment a regional framework for action 20232...
Climate change, health and environment a regional framework for action 20232...Climate change, health and environment a regional framework for action 20232...
Climate change, health and environment a regional framework for action 20232...
 
Health workforce in the Eastern Mediterranean Region from COVID-19 lessons to...
Health workforce in the Eastern Mediterranean Region from COVID-19 lessons to...Health workforce in the Eastern Mediterranean Region from COVID-19 lessons to...
Health workforce in the Eastern Mediterranean Region from COVID-19 lessons to...
 
Strengthening public health readiness for mass gatherings in the Eastern Medi...
Strengthening public health readiness for mass gatherings in the Eastern Medi...Strengthening public health readiness for mass gatherings in the Eastern Medi...
Strengthening public health readiness for mass gatherings in the Eastern Medi...
 
Addressing noncommunicable diseases in emergencies: a regional framework for ...
Addressing noncommunicable diseases in emergencies: a regional framework for ...Addressing noncommunicable diseases in emergencies: a regional framework for ...
Addressing noncommunicable diseases in emergencies: a regional framework for ...
 
Ending polio by the end of 2023.pptx
Ending polio by the end of 2023.pptxEnding polio by the end of 2023.pptx
Ending polio by the end of 2023.pptx
 
Emergencies and the IHR (2005) in the Eastern Mediterranean Region.pptx
Emergencies and the IHR (2005) in the Eastern Mediterranean Region.pptxEmergencies and the IHR (2005) in the Eastern Mediterranean Region.pptx
Emergencies and the IHR (2005) in the Eastern Mediterranean Region.pptx
 
Embrace the change National programmes for the development and adaptation of ...
Embrace the change National programmes for the development and adaptation of ...Embrace the change National programmes for the development and adaptation of ...
Embrace the change National programmes for the development and adaptation of ...
 
Minimise morbidity and mortality due to trauma in humanitarian emergencies.pptx
Minimise morbidity and mortality due to trauma in humanitarian emergencies.pptxMinimise morbidity and mortality due to trauma in humanitarian emergencies.pptx
Minimise morbidity and mortality due to trauma in humanitarian emergencies.pptx
 
Designing and implementing primary health care-oriented models of care in the...
Designing and implementing primary health care-oriented models of care in the...Designing and implementing primary health care-oriented models of care in the...
Designing and implementing primary health care-oriented models of care in the...
 
Minimizing morbidity and mortality due to trauma in humanitarian emergencies....
Minimizing morbidity and mortality due to trauma in humanitarian emergencies....Minimizing morbidity and mortality due to trauma in humanitarian emergencies....
Minimizing morbidity and mortality due to trauma in humanitarian emergencies....
 
Nomination of a Member State to the Joint Coordinating Board of the Special P...
Nomination of a Member State to the Joint Coordinating Board of the Special P...Nomination of a Member State to the Joint Coordinating Board of the Special P...
Nomination of a Member State to the Joint Coordinating Board of the Special P...
 
WHA resolutions and decisions of regional interest.pptx
WHA resolutions and decisions of regional interest.pptxWHA resolutions and decisions of regional interest.pptx
WHA resolutions and decisions of regional interest.pptx
 

الوقاية من التهاب الكبد الفيروسي ومكافحته مقترح الاستراتيجية العالمية حول التهاب الكبد

  • 1. ‫ومكافحت‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬‫ه‬ ‫ال‬ ‫التهاب‬ ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬‫كبد‬ ‫البند‬7‫من‬‫األعمال‬ ‫جدول‬ ‫المتوسط‬ ‫لشـرق‬ ‫اإلقليمية‬ ‫للجنة‬ ‫والستون‬ ‫الثانية‬ ‫الدورة‬ 5-8‫األول‬ ‫تشرين‬/‫أكتوبر‬2015‫الكويت‬ ، 1
  • 2. ً‫ا‬‫صامت‬ ً‫ء‬‫وبا‬ ‫طويلة‬ ‫لفترات‬ ‫الكبد‬ ‫التهاب‬ ‫ظل‬: ‫األرواح‬ ‫في‬ ‫كبيرة‬ ‫خسائر‬-‫التوعية‬ ‫قصور‬ 0 0.2 0.4 0.6 0.8 1 1.2 1.4 1.6 1.8 Malaria HIV TB Hepatitis ‫مليون‬ ‫العالمية‬ ‫الوفيات‬ 0 0.02 0.04 0.06 0.08 0.1 0.12 0.14 Malaria HIV TB Hepatitis ‫المتوسط‬ ‫شرق‬ ‫إقليم‬ ‫في‬ ‫الوفيات‬ Hepatitis C Hepatitis B Hepatitis A&E  2000  2013 ‫البيانات‬ ‫مصدر‬:،‫المرض‬ ‫عبء‬ ‫حول‬ ‫العالمية‬ ‫الدراسة‬2013 (GBD 2013) ‫الصحة‬ ‫مجال‬ ‫في‬ ‫والتقييم‬ ‫القياسات‬ ‫معهد‬ ‫المتحدة‬ ‫الواليات‬ ،‫سياتل‬(IHME)،2014.‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬ ‫الكبد‬ ‫التهاب‬2
  • 3. ‫العالمي‬ ‫الصعيد‬ ‫على‬ ‫الجديدة‬ ‫التطورات‬ •‫تحم‬ ‫ويمكن‬ ‫ال‬ّ‫ع‬‫وف‬ ‫جديد‬ ‫أفضل‬ ‫عالج‬‫له‬ •‫بالعمل‬ ‫وااللتزام‬ ‫العالمي‬ ‫الوعي‬ ‫زيادة‬: –‫الخطط‬‫الوطنية‬ ‫والموارد‬ –‫المدني‬ ‫المجتمع‬ ‫مشاركة‬ –‫العالميون‬ ‫الشركاء‬ –‫العالمية‬ ‫الصحة‬ ‫جمعية‬2014‫؛‬‫دعوة‬ ‫الكبد‬ ‫التهاب‬ ‫على‬ ‫للقضاء‬ ‫مستجدة‬‫؛‬ –‫المستدامة‬ ‫التنمية‬ ‫أهداف‬ ‫ا‬ ‫اللتهاب‬ ‫العالمي‬ ‫التحالف‬ ،‫بيك‬ ‫راقيل‬‫لكبد‬: "‫العالج‬ ‫أسعار‬ ‫ض‬ِّ‫نخف‬ ‫أن‬ ‫علينا‬." ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬ ‫الكبد‬ ‫التهاب‬3
  • 4. ‫الكبد‬ ‫اللتهاب‬ ‫العالمية‬ ‫االستراتيجية‬: ‫لنا‬ ‫معروفة‬ ‫الة‬‫الفع‬ ‫التدخالت‬ ‫أهم‬ •‫الكبد‬ ‫التهاب‬ ‫ضد‬ ‫التطعيم‬B(‫الوالدة‬ ‫عند‬ ‫اللقاح‬ ‫جرعة‬ ‫ذلك‬ ‫في‬ ‫بما‬) •‫المأمون‬ ‫والدم‬ ‫اآلمن‬ ‫الحقن‬ ‫ممارسات‬ •‫الضرر‬ ‫من‬ ‫الحد‬‫لمتعاطي‬‫ي‬‫المخدرات‬ •‫المأمون‬ ‫الجنسي‬ ‫السلوك‬ ‫تشجيع‬ •‫الكبد‬ ‫التهاب‬ ‫عالج‬B •‫الكبد‬ ‫التهاب‬ ‫عالج‬C ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬ ‫الكبد‬ ‫التهاب‬4
  • 5. ‫الكبد‬ ‫اللتهاب‬ ‫العالمية‬ ‫االستراتيجية‬:‫ال‬‫غايات‬ •‫باألثر‬ ‫الخاصة‬ ‫الغايات‬ ‫مقترح‬(‫بحلول‬2030) •‫التدخالت‬ ‫بأهم‬ ‫التغطية‬ ‫غايات‬ ‫تدعمها‬ ‫التهاب‬ ‫من‬ ‫الجديدة‬ ‫الحاالت‬ ‫خفض‬ ‫الكبد‬B‫و‬C‫بنسبة‬90% ‫التهاب‬ ‫عن‬ ‫الناجمة‬ ‫الوفيات‬ ‫خفض‬ ‫الكبد‬B‫و‬C‫بنسبة‬65% ‫التدخل‬،‫األساسية‬ ‫النسبة‬ 2015 20202030 ‫الكبد‬ ‫التهاب‬ ‫ضد‬ ‫التطعيم‬B ‫الكبد‬ ‫التهاب‬ ‫ضد‬ ‫التطعيم‬B‫عند‬ ‫الوالدة‬ 81% 38% 90% 50% 90% 90% ‫اآلمن‬ ‫الحقن‬5%‫بنسبة‬ ‫تغطية‬50%90% ‫الكبد‬ ‫التهاب‬ ‫عالج‬B‫من‬ ‫أقل‬1%‫عالج‬8‫شخص‬ ‫ماليين‬ (5‫الكبد‬ ‫التهاب‬ ‫من‬ ‫ماليين‬B، ‫و‬3‫الكبد‬ ‫التهاب‬ ‫من‬ ‫ماليين‬C) 80% ‫الكبد‬ ‫التهاب‬ ‫عالج‬C‫من‬ ‫أقل‬1%80% ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬ ‫الكبد‬ ‫التهاب‬5
  • 6. ‫اإلقل‬ ‫في‬ ‫المقترحة‬ ‫المستقبلية‬ ‫الخطوات‬‫يم‬ •‫والبلدا‬ ‫للمنظمة‬ ‫اإلقليمية‬ ‫العمل‬ ‫خطة‬‫ن‬ •‫إجراءات‬‫للظروف‬ ‫مالئمة‬‫البلدان‬ ‫في‬ (‫الوطنية‬ ‫بالخطط‬ ‫تسترشد‬،‫وتست‬‫إلى‬ ‫ند‬ ‫المرض‬ ‫عبء‬ ‫تحليل‬،‫على‬ ‫وتركز‬ ‫فاعلية‬ ‫األكثر‬ ‫االستثمارات‬) ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬ ‫الكبد‬ ‫التهاب‬6
  • 7. ً‫ا‬‫وشكر‬ً‫ال‬‫جزي‬ http://www.emro.who.int/health-topics/hepatitis/index.html ‫حول‬ ‫العالمية‬ ‫االستراتيجية‬ ‫مقترح‬ ‫ومكافحته‬ ‫الفيروسي‬ ‫الكبد‬ ‫التهاب‬ ‫من‬ ‫الوقاية‬ ‫الكبد‬ ‫التهاب‬7

Editor's Notes

  1. Excellencies Ministers of Health, delegates and colleagues, Last year, the World Health Assembly re-iterated its concern about Hepatitis being a global public health threat and its call upon WHO to develop a global Hepatitis strategy. With this short talk we would like to update on recent global developments and bring the draft global hepatitis strategy to your attention, which will be discussed at the Executive Board meeting in January 2016.
  2. Hepatitis has long been a silent epidemic. Globally, there is an estimated 400 million people living with hepatitis B or hepatitis C infection. No country or region is unaffected. 1.4 million people die every year from complications of viral hepatitis yet most of these deaths can be prevented. Still there is a lack of awareness and most persons with hepatitis remain undiagnosed. In the WHO Eastern Mediterranean Region viral hepatitis B and C is causing more deaths than each of HIV, Malaria and Tuberculosis. Two of the countries with the highest burden of Hepatitis C in the world are in this Region: Pakistan and Egypt.   Mortality data shown on this slide stem from the Institute of Health Metrics and Evaluation’ global burden of disease database. The data represent outputs of estimation models which are based on available country data. Hepatitis B: ~ 4.3 million new HBV infections / year Hepatitis C: ~ 800,000 new HCV infections / year  
  3. There are, however, some encouraging global developments. New, more effective and tolerable medicines make treatment more feasible. WHO has included several of those medicines in the WHO essential drug list. However, affordability of those medicines has been an issue since prices have been very high. Meanwhile several countries, foremost Egypt but also the private sector in Pakistan have negotiated prices as low as 1% of the price paid in the US. Also, Moreover, recently generica have been entering the market and some countries, including Morocco and Egypt have started local production. Gilead, the producer of Sofosbuvir, has initiated an access program which allows most low income countries to purchase Sofosbuvir and Harvoni at preferential prices. We also observe increased global awareness and commitment: Countries develop national plans for Hepatitis and allocate additional resources. Civil society engages. Patient voices and demands are becoming louder and are being heard. Some global partners expand their scope to include Hepatitis, such as Medicins sans Frontieres, UNITAID and the Clinton HIV/AIDS Initiative. A call for Hepatitis elimination as a major public health threat is emerging. This has first been expressed at the World Health Assembly in 2014 where WHO was asked to examine the “feasibility of and strategies needed for the elimination of hepatitis B and hepatitis C with a view to setting global targets”. Extensive data collection and their use for modeling of Hepatitis epidemiology and the impact of interventions has so far led to the conclusion that viral hepatitis B and C can be eliminated as a public health issue of concern. Sustained transmission can be removed as well as hepatitis as a leading cause of mortality. This is technical feasible by scaling up six key interventions to high coverage.  
  4. The key interventions to reduce new infections and to prevent severe disease and deaths of Hepatitis B and C are well known. They range from vaccination, safe injection practices, safe blood, harm reduction for drug users, safe sexual behaviour including protection through condoms to treating infected patients to keep the virus under control or even eliminate it completely from the infected person. Coverage of those interventions varies largely globally and in the Region, but it is inadequate in the majority of countries.
  5. With the view towards eliminating Hepatitis B and C as a public health issue of concern the proposed global hepatitis strategy suggests targets for reducing new infections and mortality by 2030. The aim is to achieve a 90% reduction of new infections and a 65% reduction deaths due to chronic Hepatitis B and C. Those impact targets are supported by coverage targets for key interventions. The table shows 2020 milestones and 2030 targets for some of the key interventions. The current draft strategy and these targets were developed in consultation with a wide range of stakeholders and try to balance feasibility with ambition. They will require massive efforts in terms of Hepatitis B vaccination at birth, injection safety and treatment scale up.
  6. What we propose as next steps in the Region: EMRO shall engage Ministries of Health, regional Hepatitis experts, patient organizations, the private sector and partner agencies in developing a regional Hepatitis action plan based on the global strategy. We hope to present this plan at the next Regional Committee for endorsement. Ministries of Health are encouraged to develop national targets and plans through a similar consultative process so to get all stakeholders on board needed to master the challenging tasks ahead. Egypt has been particularly proactive in this regard. An ambitious national plan is the basis of a huge effort to confront the major Hepatitis C epidemic. We will now have the opportunity to learn more about this Egyptian experience.